Home

Interveni Apos nepoată puma biotechnology Ilumina Linia de vedere Premoniţie

Henry Kuo - Head of Information Technology - Puma Biotechnology, Inc. |  LinkedIn
Henry Kuo - Head of Information Technology - Puma Biotechnology, Inc. | LinkedIn

Puma Biotechnology, Inc. 2022 Q4 - Results - Earnings Call Presentation  (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology, Inc. 2022 Q4 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha

Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters
Puma Biotech agrees to pay investors $54.2 mln in fraud case | Reuters

Puma Biotechnology falls more than 20%
Puma Biotechnology falls more than 20%

Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital |  citybiz
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | citybiz

Puma Biotechnology Announces Exclusive License Agreement with Takeda for  the Development and Commercialization of Alisertib, an Investigational  Aurora Kinase A Inhibitor | Business Wire
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire

What Happened To Puma Biotechnology?
What Happened To Puma Biotechnology?

Puma Biotechnology
Puma Biotechnology

Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking  Alpha
Puma Biotechnology: Still Bullish At These Prices (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology
Puma Biotechnology

Articles with Puma Biotechnology
Articles with Puma Biotechnology

Puma Biotechnology
Puma Biotechnology

Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023
Puma Biotechnology Inc (PBYI) Stock Price & Performance 2023

Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet
Why Puma Biotechnology (PBYI) Stock Is Surging Today - TheStreet

Former Puma Biotech executive gets U.S. prison term for insider trading |  Reuters.com
Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters.com

Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business
Why Puma Biotechnology, Inc. Stock Crashed 37% in March | Fox Business

Puma Biotechnology
Puma Biotechnology

Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors  think so | Fierce Pharma
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | Fierce Pharma

Puma Biotechnology (PBYI) - 5 Price Charts 2012-2023 (History)
Puma Biotechnology (PBYI) - 5 Price Charts 2012-2023 (History)

Puma Biotechnology Careers | Wellfound (formerly AngelList Talent)
Puma Biotechnology Careers | Wellfound (formerly AngelList Talent)

Puma Biotechnology, Inc. (PBYI) Company Information - Simply Wall St
Puma Biotechnology, Inc. (PBYI) Company Information - Simply Wall St

Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) |  Seeking Alpha
Puma Biotechnology up 15% after quarterly earnings beats (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology: Risky Investment (NASDAQ:PBYI) | Seeking Alpha

Puma Biotechnology Announces Exclusive License Agreement with Takeda for  the Development and Commercialization of Alisertib, an Investigational  Aurora Kinase A Inhibitor | Business Wire
Puma Biotechnology Announces Exclusive License Agreement with Takeda for the Development and Commercialization of Alisertib, an Investigational Aurora Kinase A Inhibitor | Business Wire